STK38 Kinase Promotes Cell Migration Induced by Oncogenic Ras via MerTK Activation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110388 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Satoshi Ohta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Structural Biochemistry, Department of Biochemistry, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan. Hauptthemen laut MEDLINE: c-Mer Tyrosine Kinase, Cell Movement, Protein Serine-Threonine Kinases, ras Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research, Grants-in-Aid for Scientific Research from MEXT.
Abstract (Originalsprache)
Ras gene mutations are frequently observed in many types of cancers. However, there are currently no effective anticancer drugs against Ras-induced cancers. Therefore, identifying the downstream effectors of the Ras signaling pathway can facilitate the development of promising novel therapeutic approaches. We previously showed that oncogenic Ras induces the expression of the receptor tyrosine kinase c-Mer proto-oncogene tyrosine kinase (MerTK) in an interleukin-1 family member NF-HEV/IL-33-dependent manner and that IL-33 and MerTK contribute to oncogenic Ras-induced cell migration. In the present study, we purified the MerTK complex from NIH-3T3 cells transformed by the expression of oncogenic Ras, H-Ras (G12V). Mass spectrometric analysis identified STK38 (also known as NDR1) as a candidate binding partner for MerTK. STK38 is a serine/threonine protein kinase that plays diverse roles in normal and cancerous cells. In addition to MerTK knockdown, STK38 knockdown effectively attenuated the H-Ras (G12V)-induced migration of NIH-3T3 cells. STK38 kinase activity is required for oncogenic Ras-induced cell migration and MerTK tyrosine phosphorylation. Furthermore, MerTK or STK38 knockdown attenuated the activation of Rac1 and Cdc42. Taken together, these results revealed a novel role for STK38 in oncogenic Ras-induced enhanced cell migration, which may be useful for developing novel therapeutic strategies targeting Ras-mutated cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Structural Biochemistry, Department of Biochemistry, Jichi Medical University, Shimotsuke 329-0498, Tochigi, Japan.
- Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, 3-39-22 Showa-Machi, Maebashi 371-8514, Gunma, Japan.
ORCID-Profile: Satoshi Ohta, Kaoru Tominaga
Förderung
- Grants-in-Aid for Scientific Research
- Grants-in-Aid for Scientific Research from MEXT
Zitieren
APA
Ohta, S., Tago, K., Kasashima, K., Ebina, M., & Tominaga, K. (2025). STK38 Kinase Promotes Cell Migration Induced by Oncogenic Ras via MerTK Activation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110388
Vancouver
Ohta S, Tago K, Kasashima K, Ebina M, Tominaga K. STK38 Kinase Promotes Cell Migration Induced by Oncogenic Ras via MerTK Activation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110388
BibTeX
@article{Ohta2025,
author = {Ohta, Satoshi and Tago, Kenji and Kasashima, Katsumi and Ebina, Masayuki and Tominaga, Kaoru},
title = {STK38 Kinase Promotes Cell Migration Induced by Oncogenic Ras via MerTK Activation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110388}
}
EUVIMED